JP Morgan Chase’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-251,613
| Closed | -$2.59M | – | 8068 |
|
|
2023
Q3 | $2.59M | Buy |
251,613
+242,898
| +2,787% | +$2.3M | ﹤0.01% | 3360 |
|
|
2023
Q2 | $71.9K | Sell |
8,715
-308,222
| -97% | -$1.84M | ﹤0.01% | 5612 |
|
|
2023
Q1 | $1.77M | Buy |
316,937
+208,664
| +193% | +$1.19M | ﹤0.01% | 3621 |
|
|
2022
Q4 | $536K | Buy |
108,273
+13,432
| +14% | +$55.3K | ﹤0.01% | 4468 |
|
|
2022
Q3 | $455K | Sell |
94,841
-54,900
| -37% | -$235K | ﹤0.01% | 4525 |
|
|
2022
Q2 | $385K | Sell |
149,741
-85,976
| -36% | -$323K | ﹤0.01% | 4723 |
|
|
2022
Q1 | $1.36M | Buy |
235,717
+147,555
| +167% | +$1.32M | ﹤0.01% | 4057 |
|
|
2021
Q4 | $1.32M | Sell |
88,162
-3,505
| -4% | -$63.8K | ﹤0.01% | 4180 |
|
|
2021
Q3 | $2.4M | Buy |
91,667
+74,723
| +441% | +$2.75M | ﹤0.01% | 3646 |
|
|
2021
Q2 | $847K | Buy |
16,944
+932
| +6% | +$41.7K | ﹤0.01% | 4398 |
|
|
2021
Q1 | $737K | Buy |
16,012
+4,969
| +45% | +$237K | ﹤0.01% | 4435 |
|
|
2020
Q4 | $473K | Buy |
11,043
+3,410
| +45% | +$129K | ﹤0.01% | 4402 |
|
|
2020
Q3 | $308K | Sell |
7,633
-8,410
| -52% | -$419K | ﹤0.01% | 4182 |
|
|
2020
Q2 | $878K | Sell |
16,043
-27,728
| -63% | -$1.59M | ﹤0.01% | 3588 |
|
|
2020
Q1 | $2.29M | Buy |
43,771
+37,436
| +591% | +$2.03M | ﹤0.01% | 2868 |
|
|
2019
Q4 | $308K | Sell |
6,335
-7,348
| -54% | -$344K | ﹤0.01% | 4498 |
|
|
2019
Q3 | $752K | Sell |
13,683
-6,382
| -32% | -$365K | ﹤0.01% | 3992 |
|
|
2019
Q2 | $988K | Buy |
20,065
+14,194
| +242% | +$706K | ﹤0.01% | 3882 |
|
|
2019
Q1 | $332K | Sell |
5,871
-14
| -0.2% | -$834 | ﹤0.01% | 4399 |
|
|
2018
Q4 | $375K | Sell |
5,885
-29,218
| -83% | -$2.07M | ﹤0.01% | 4277 |
|
|
2018
Q3 | $2.85M | Sell |
35,103
-165,088
| -82% | -$12.1M | ﹤0.01% | 3201 |
|
|
2018
Q2 | $12.8M | Buy |
200,191
+106,322
| +113% | +$5.22M | ﹤0.01% | 1947 |
|
|
2018
Q1 | $3.64M | Buy |
93,869
+31,353
| +50% | +$1.1M | ﹤0.01% | 2835 |
|
|
2017
Q4 | $1.75M | Buy |
62,516
+41,643
| +200% | +$1.22M | ﹤0.01% | 3400 |
|
|
2017
Q3 | $563K | Buy |
+20,873
| New | +$398K | ﹤0.01% | 3789 |
|
|
2017
Q2 | – | Sell |
-3,330
| Closed | -$45K | – | 5300 |
|
|
2017
Q1 | $45K | Sell |
3,330
-3,425
| -51% | -$49.2K | ﹤0.01% | 4556 |
|
|
2016
Q4 | $101K | Buy |
+6,755
| New | +$86.5K | ﹤0.01% | 4398 |
|
Other funds holding TRHC
JP Morgan Chase's TRHC Position: Q4 2023 in Review
JP Morgan Chase sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 251,613 shares — an estimated $2.59M sold.
JP Morgan Chase first reported a position in TRHC in Q4 2016 and held it in 27 quarters. The position peaked at $12.8M in Q2 2018. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- JP Morgan Chase reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- JP Morgan Chase sold 251,613 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $2.59M.
- JP Morgan Chase first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 27 quarters.
- JP Morgan Chase's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $12.8M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.